'Game-changer': Tests using cerebrospinal fluid samples can help in early diagnosis of Parkinson's disease, says study
Parkinson's is the second most common neurodegenerative disease after Alzheimer's and affects more than 8.5 million people worldwide, according to WHO. There is no cure or way to test for the disease, which is usually diagnosed by a doctor only once symptoms appear